Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Flutiform
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Flutiform 125micrograms/dose / 5micrograms/dose inhaler
0302000N0BDAABJ
|
Flutiform | Fluticasone propionate (Inhalation) | Respiratory System | 56,854 |
|
Flutiform 250micrograms/dose / 10micrograms/dose inhaler
0302000N0BDABBK
|
Flutiform | Fluticasone propionate (Inhalation) | Respiratory System | 46,067 |
|
Flutiform 50micrograms/dose / 5micrograms/dose inhaler
0302000N0BDACBL
|
Flutiform | Fluticasone propionate (Inhalation) | Respiratory System | 20,430 |
|
Flutiform K-haler 125microg/dose / 5microg/dose BA inhaler
0302000N0BDADBP
|
Flutiform | Fluticasone propionate (Inhalation) | Respiratory System | 456 |
|
Flutiform K-haler 50microg/dose / 5microg/dose BA inh
0302000N0BDAEBQ
|
Flutiform | Fluticasone propionate (Inhalation) | Respiratory System | 285 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.